Abstract
The intrinsic apoptotic pathway is controlled by the BCL-2 family of proteins, which exhibit either a pro-death or pro-survival function. Gene knockout studies revealed that different pro-survival BCL-2 proteins are critical for the survival of distinct cell types, although overlapping functions amongst such proteins have also been identified. In the process of studying mice lacking single alleles of Mcl-1 (Mcl-1+/−), Bcl-2 (Bcl-2+/−), or both in combination (Mcl-1+/−Bcl-2+/−), we observed that Mcl-1+/−Bcl-2+/− mice weighed less when compared with their wild-type littermates as they aged. Body composition analysis demonstrated that while fat mass was similar to wild-type controls, lean mass was significantly reduced in Mcl-1+/−, Bcl-2+/−, and, most strikingly in Mcl-1+/−Bcl-2+/− mice. The weights of several tissues including the heart, tibialis anterior, and kidney were likewise reduced in Mcl-1+/−Bcl-2+/− mice. When lean mass and specific tissue weights were expressed relative to body weight, these differences were no longer significant, indicating that that Mcl-1+/−Bcl-2+/− mice, and to a lesser extent Mcl-1+/− and Bcl-2+/− mice, are smaller than their wild-type counterparts. Consistently, the anal-naso length was reduced in Mcl-1+/−Bcl-2+/− mice. While minor reductions in size were observed in female Mcl-1+/−Bcl-2+/− mice, these effects were most prominent in males. Notably, Mcl-1+/−Bcl-2+/− males had markedly smaller testes even after accounting for differences in body weight. Collectively, these data reveal that combined loss of a single allele of Mcl-1 and Bcl-2, while not overtly impairing organismal development, leads to a reduction in animal size.
Similar content being viewed by others
Introduction
The intrinsic (also called the BCL-2-regulated or mitochondrial) apoptotic pathway, is a physiological process that is regulated by the BCL-2 family of proteins1,2. It contributes to diverse functions, including maintaining cellular homeostasis, sculpting the embryo by removing excess structures during development, and eliminating damaged or infected cells1,2,3. All members of the BCL-2 family share domains of homology (called BCL-2 homology (BH) domain) and can be divided into two groups based on their function to promote cell survival (BCL-2, BCL-XL, BCL-W, MCL-1, BFL-1/A1), or cell death. The pro-apoptotic members are further classified into two groups—the multi-BH domain proteins (BAX, BAK, BOK) that execute cell death and the BH3-only proteins that contain only the BH3 domain (BAD, BID, BIK, BIM, BMF, HRK, NOXA, PUMA) and act as initiators of apoptosis signalling1,2,4.
In response to cytotoxic stimuli, such as DNA damage, or developmental cues, the expression of BH3-only proteins is induced transcriptionally or post-transcriptionally5. These initiators of apoptosis bind to and inhibit the pro-survival BCL-2 proteins thereby liberating BAX and BAK to permeabilise the mitochondrial outer membrane (MOMP). This causes the release of apoptogenic proteins (e.g., cytochrome c) from the mitochondria that activate caspases to orchestrate cellular demolition1,2,4. Certain BH3-only proteins, such as BIM and PUMA, have been reported to also be able to directly activate BAX/BAK to induce MOMP and apoptosis1,2,4.
Earlier work aimed to determine the roles of various BCL-2 family members in cancer and embryonic development through the study of single, as well as multiple gene knockout mice3,6. Such studies revealed that systemic loss of either pro-survival MCL-17 or BCL-XL8 resulted in embryonic lethality, while the loss of BCL-2 gave rise to runty animals that succumbed to polycystic kidney disease at a young age (4–7 weeks post-birth)9,10. We examined the overlapping roles of different pro-survival BCL-2 family members by generating Mcl-1+/−Bcl-x+/−, Mcl-1+/−Bcl-2+/− and Bcl-x+/−Bcl-2+/− mice. While the combined loss of single alleles of Mcl-1 and Bcl-x disrupted normal embryogenesis and gave rise to animals with severe craniofacial abnormalities, with most dying soon after or even before birth, these defects were prevented by the deletion of a single allele of the pro-apoptotic BH3-only protein, BIM6. In contrast, Mcl1+/−Bcl-2+/− and Bcl-x+/−Bcl-2+/− mice appeared grossly normal and were long-lived6.
However, in the course of maintaining these colonies, we observed that double heterozygote Mcl-1+/−Bcl-2+/− mice gained less weight as they aged in comparison to their wild-type (WT) counterparts. This reduced weight gain was due to reduced growth, with male Mcl-1+/−Bcl-2+/− mice displaying lower lean mass, tissue weights, and a commensurate decrease in body length. However, their fat mass remained normal and no overt developmental anomalies were observed in comparison to WT animals.
Results
Mice lacking a single allele of Mcl-1 and a single allele of Bcl-2 are smaller in size compared to WT animals
Over the course of breeding Mcl-1+/− and Bcl-2+/− animals, we noticed that mice lacking single alleles of Mcl-1 or Bcl-2, and in particular the Mcl-1+/−Bcl-2+/− double heterozygotes, gained less weight and were smaller than WT controls (Fig. 1a–c).
We initially considered that Mcl-1+/−Bcl-2+/− mice may be protected from the development of age-related obesity. Therefore, to determine whether the observed weight differences could be attributed to alterations in fat mass, we assessed body composition by EchoMRI11 to measure body mass (Fig. 2a, b), fat mass (Fig. 2c, d), and lean mass (Fig. 2e, f) in an independent cohort of aged male and female WT, Mcl-1+/−, Bcl-2+/− and Mcl-1+/−Bcl-2+/− animals. In contrast to our hypothesis, no differences in fat mass were observed between the genotypes examined (Fig. 2a, b). However, a striking difference in lean mass was evident between WT and Mcl-1+/−Bcl-2+/− mice, which was more pronounced in males than females (compare Fig. 2e, f). Consistent with these data, we explored the overall size of the mice and noted a significant decrease in measured body length (naso-anal length) and tibia length in male Mcl-1+/−Bcl-2+/− animals when compared with WT controls (Fig. 2g–j).
To further assess the reduced lean mass phenotype observed, we explored the weights of several major organs. Heart (Fig. 3a, b), tibialis anterior muscle (TA) (Fig. 3c, d), kidney (Fig. 3e, f) and spleen weights (Fig. 3g, h) were also all significantly reduced in male Mcl-1+/−Bcl-2+/− animals when compared with WT controls. We observed a similar trend in Mcl-1+/−, as well as Bcl-2+/− single heterozygote male mice, although the magnitude of these changes was smaller in comparison to the Mcl-1+/−Bcl-2+/− double heterozygote animals. Female Mcl-1+/−Bcl-2+/− mice also displayed a significant reduction in body length (Fig. 2h), TA (Fig. 3d), kidney (Fig. 3f) and spleen weight (Fig. 3h) compared to WT controls. No significant differences in liver weights were observed across the genotypes in mice of both sexes (Fig. 3i, j). From kidney histology sections, we counted the number of nuclei within proximal and distal tubules per field from images of the renal cortex in multiple WT and Mcl-1+/−Bcl-2+/− male mice. The numbers of nuclei/field were not different between genotypes (data not shown), indicating that the above described reductions in organ weights are likely due to reductions in the total number of cells per organ rather than decreases in cell size.
In the initial cohort of aged males studied, testes weights were not included in our analyses. However, this information was subsequently recorded along with body mass (Fig. 4a) in a second batch of younger male mice (mean age = 278 days). In this cohort we again observed that Mcl-1+/−Bcl-2+/− males consistently displayed reduced weight in comparison with WT controls. Furthermore, Mcl-1+/−, Bcl-2+/− and Mcl-1+/−Bcl-2+/− males had a significant decrease in testicle weights compared to WT males (Fig. 4b), which was most striking in Mcl-1+/−, as well as Mcl-1+/−Bcl-2+/− mice. To determine whether this difference was due to anomalies in testes development, we performed histological examination on WT, Mcl-1+/−, Bcl-2+/−, and Mcl-1+/−Bcl-2+/− age-matched male mice. However, mice of all genotypes examined were fertile and no obvious differences in testes morphology were observed (Fig. 4c).
Since male mice displayed a more obvious phenotype compared to females, we examined the former in greater detail. When expressed relative to body weight, the TA muscle, heart, kidney weights and total lean mass (all of which were reduced in Mcl-1+/−Bcl-2+/− males) were no longer significantly different between any of the genotypes (Fig. 5a–d). Interestingly, liver weights, which were unaffected by genotype (Fig. 3i), were increased in Mcl-1+/−Bcl-2+/− males after normalisation to body weight (Fig. 5e). Spleen (Fig. 5f) and testes weights (Fig. 5g) remained significantly lower even after normalisation to body weight.
Histological analysis of major organs revealed no significant differences in the spleen and liver of mice with different genotypes
To further examine the spleen and liver, histological analysis was performed on tissue samples from age-matched mice of the different genotypes (Supplementary Fig. 1). Across all genotypes, we observed varying levels of fat in the liver along with perivascular infiltration, as well as an expansion of the lymphoid areas in the spleen in a proportion of the animals. However, no obvious differences were found between groups. Since the age of the cohort examined was over a year old, these observations were most likely attributable to aging.
WT, Mcl-1 +/−, Bcl-2 +/−, and Mcl-1 +/−Bcl-2 +/− mice display similar levels of serum testosterone and IGF-1 levels
The testes produce anabolic hormones, such as testosterone, that have a major role in muscle and bone growth. We considered that the markedly reduced testes weight, and potentially a concomitant reduction in testosterone production, may be a primary driver of the abnormally reduced growth in male Mcl-1+/−Bcl-2+/− mice. However, we observed no differences in serum testosterone levels between mice of any of the genotypes tested (Fig. 6a). Similarly, no differences in IGF1, another major anabolic hormone, were observed between mice of the different genotypes (Fig. 6b).
Discussion
We have shown that Mcl-1+/−Bcl-2+/− mice, and to a lesser extent Mcl-1+/− and Bcl-2+/− mice, are smaller than their WT counterparts. While this effect was apparent in females, it was markedly more pronounced in males. When we first noted that Mcl-1+/−Bcl-2+/− animals appeared smaller than single heterozygote and WT animals, we hypothesised that this may have been due to a reduction in fat mass. However, EchoMRI analysis revealed that fat mass was similar between WT, Mcl-1+/−, Bcl-2+/−, and Mcl-1+/−Bcl-2+/− mice, and the reduction in body weight was entirely attributable to lower lean mass. Consistently, we also observed reductions in the weights of numerous tissues in Mcl-1+/−Bcl-2+/− mice. Importantly, Mcl-1+/−Bcl-2+/− males had a lower naso-anal length and tibia length compared to WT controls. When expressed relative to body weight, differences in lean mass, as well as weights of the heart, kidney and TA muscle were not significant between the genotypes examined. Collectively, our data indicate that Mcl-1+/−Bcl-2+/− mice, and to a lesser extent Mcl-1+/− and Bcl-2+/− mice have a reduced organismal size compared with their WT counterparts and this appears to be due to a reduction in cell numbers per tissue (rather than a decrease in cell size). Interestingly, the spleen and testes of Mcl-1+/Bcl-2+/− mice remained significantly smaller compared to control animals even when expressed relative to overall body weight.
The anti-apoptotic roles of MCL-1 and BCL-2 in immune cell survival have been well documented, and it is therefore not unexpected that the spleen weights were reduced in Mcl-1+/− and Bcl-2+/− mice9,12, and further reduced in Mcl-1+/−Bcl-2+/− double heterozygotes (Fig. 3g). Interestingly, the effects of Mcl-1 and/or Bcl-2 deficiency on spleen weight was less pronounced in female mice (Fig. 3g). This may suggest that male hormones exacerbate the impairment in cell survival caused by the reduction in BCL-2 and/or MCL-1. Alternatively, female hormones could have a protective effect.
With regards to the reduction in testes weight observed in Mcl-1+/−Bcl-2+/− males, apoptosis is known to play a key role in spermatogenesis, with only 25% of germ cells successfully maturing and the remainder undergoing apoptosis in the early post-natal period13. These high rates of apoptosis are essential to establish the appropriate balance between germ cells and Sertoli cells, which support the survival, proliferation, and maturation of the former. Several BCL-2 family members are expressed in the testes and display distinct patterns of expression during testes development14. Moreover, previous studies have established important roles for BCL-2 family members in spermatogenesis and testes development. Mice deficient in the pro-apoptotic effector BAX, those lacking BH3-only proteins BIK and BIM, those lacking pro-survival BCL-W, or expressing a Bcl-2 transgene, all exhibit dysregulated apoptosis, disorganised spermatogenesis, and altered testes weight14,15,16,17. This suggests that both abnormally increased, as well as abnormally decreased apoptosis can cause defects in spermatogenesis. Our observations of significantly reduced testes weight in Mcl-1+/−Bcl-2+/− males are consistent with these prior findings and suggest an important role for MCL-1 and BCL-2 in testes development.
We have previously shown that the body weight of E19.5 Mcl-1+/− pups was significantly lower than WT littermates6, and observed that Mcl-1+/− mice developed normally and survive into late adulthood6. These findings are consistent with the current observations and suggest that the reduction in MCL-1 either alone or in combination with a reduction in BCL-2 likely affects numerous aspects of organismal development and growth. This may be explained by an abnormal increase in apoptosis, leading to reduced cell numbers in early embryogenesis that will carry through to a reduction in overall body cellularity and thus body size. Importantly, with the exception of being smaller in size, Mcl-1+/−Bcl-2+/− double heterozygote mice do not display any overt developmental defects. Collectively, our results demonstrate rate limiting roles for MCL-1 and BCL-2 in organismal growth.
Methods
Mice
All experiments were approved by the animal ethics committees of the Walter and Eliza Hall Institute of Medical Research and the Baker Heart and Diabetes Institute and conducted in accordance with the Australian code for the care and use of laboratory animals. Mcl-1+/− mice were generated from Mcl-1fl/+ mice18. The Mcl-1+/− and Bcl-2+/−10 were all maintained on a C57BL/6 background. All mice were bred and aged at the Walter and Eliza Hall Institute of Medical Research and were maintained in a 14-h light and 10-h dark cycle at 22 °C and fed ad libitum on standard mouse chow. Once the cohorts had aged they were transferred to the Baker Heart and Diabetes Institute, where they were habituated in the new environment for ~2 weeks before assessment of body mass and body composition. Approximately 1 week after the assessment of body composition, mice were culled and body length, tissue weights, and tibia length determined.
Body composition and mass
Lean and fat mass were determined using a 4-in-1 EchoMRI body composition analyser (EchoMRITM, Houston, TX, USA), as previously described11. Standard laboratory scales were used to determine total body mass (Mettler Toledo, Greifensee, Switzerland).
Statistical analysis
The data presented in Fig. 1 were analysed using a 2-way (genotype x time) analysis of variance (ANOVA) with repeated measures on the time factor. Where a significant interaction effect was observed, statistical analysis of specific pairwise comparisons was conducted using a post-hoc Tukey test. Data in Figs. 2–6 were analysed by 1-way ANOVA using the PRISM software. Where the ANOVA revealed a significant F value, statistical analysis of specific pairwise comparisons was conducted using the Tukey’s test, which adjusts P values for multiple comparisons. Where statistical significance was achieved, the adjusted P values are reported within the specific figures.
Histology
All mouse tissues were fixed in 10% buffered formalin solution and subsequently embedded in paraffin prior to sectioning. Slides were stained with haematoxylin and eosin, then examined and photographed using the CaseViewer Software (3DHISTECH).
ELISA
ELISAs for testosterone (KGE010) and IGF1 (MG100) were obtained from R&D systems and performed according to the manufacturer’s instructions.
References
Czabotar, P. E., Lessene, G., Strasser, A. & Adams, J. M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49–63 (2014).
Moldoveanu, T., Follis, A. V., Kriwacki, R. W. & Green, D. R. Many players in BCL-2 family affairs. Trends Biochem. Sci. 39, 101–111 (2014).
Ke, F. F. S. et al. Embryogenesis and adult life in the absence of intrinsic apoptosis effectors BAX, BAK, and BOK. Cell 173, 1217–1230 e1217 (2018).
Singh, R., Letai, A. & Sarosiek, K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20, 175–193 (2019).
Puthalakath, H. & Strasser, A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9, 505–512 (2002).
Grabow, S. et al. Subtle changes in the levels of BCL-2 proteins cause severe craniofacial abnormalities. Cell Rep. 24, 3285–3295 e3284 (2018).
Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K. & Korsmeyer, S. J. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 14, 23–27 (2000).
Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506–1510 (1995).
Bouillet, P., Cory, S., Zhang, L. C., Strasser, A. & Adams, J. M. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev. Cell 1, 645–653 (2001).
Veis, D. J., Sorenson, C. M., Shutter, J. R. & Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229–240 (1993).
Lancaster, G. I. & Henstridge, D. C. Body composition and metabolic caging analysis in high fat fed mice. J. Vis. Exp. 135, e57280 (2018).
Brinkmann, K. et al. The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice. Cell Death Differ. 24, 2032–2043 (2017).
Print, C. G. & Loveland, K. L. Germ cell suicide: new insights into apoptosis during spermatogenesis. Bioessays 22, 423–430 (2000).
Meehan, T., Loveland, K. L., de Kretser, D., Cory, S. & Print, C. G. Developmental regulation of the bcl-2 family during spermatogenesis: insights into the sterility of bcl-w-/- male mice. Cell Death Differ. 8, 225–233 (2001).
Coultas, L. et al. Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis. EMBO J. 24, 3963–3973 (2005).
Furuchi, T., Masuko, K., Nishimune, Y., Obinata, M. & Matsui, Y. Inhibition of testicular germ cell apoptosis and differentiation in mice misexpressing Bcl-2 in spermatogonia. Development 122, 1703–1709 (1996).
Knudson, C. M., Tung, K. S., Tourtellotte, W. G., Brown, G. A. & Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96–99 (1995).
Vikstrom, I. et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 330, 1095–1099 (2010).
Acknowledgements
We thank Drs. P. Bouillet and S. Korsmeyer for gifts of mice; G. Siciliano, A. Coad, C. Stivala and the AMREP precinct animal facility for animal care; K. Weston for blood cell analysis; B. Helbert and R. Chan for genotyping and the WEHI histology facility for histological preparations. This work was supported by grants and fellowships from the Leukaemia Foundation Australia (to F.K., S.G.), Cancer Council Victoria (to F.K., S.G.), Lady Tata Memorial Trust International Research Award (to S.G.) and the National Health and Medical Research Council (Program Grant #1016701, Project grant #1086291, Fellowship #1020363; all to A.S.). This work was made possible by the operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by G. Melino
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ke, F., Lancaster, G.I., Grabow, S. et al. Combined reduction in the expression of MCL-1 and BCL-2 reduces organismal size in mice. Cell Death Dis 11, 185 (2020). https://doi.org/10.1038/s41419-020-2376-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-020-2376-5
This article is cited by
-
ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway
Journal of Molecular Histology (2023)
-
MicroRNA-specific therapeutic targets and biomarkers of apoptosis following myocardial ischemia–reperfusion injury
Molecular and Cellular Biochemistry (2023)
-
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Cell Death & Differentiation (2023)